Horizon Investment Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Buy
30,892
+180
+0.6% +$12.7K 0.69% 46
2025
Q4
$2.07M Buy
30,712
+422
+1% +$28.4K 0.74% 37
2025
Q3
$2.22M Buy
30,290
+3,228
+12% +$214K 0.84% 35
2025
Q2
$1.41M Buy
27,062
+12,596
+87% +$717K 0.62% 42
2025
Q1
$923K Buy
14,466
+9,707
+204% +$564K 0.45% 54
2024
Q4
$228K Sell
4,759
-23,707
-83% -$1.22M 0.1% 115
2024
Q3
$1.63M Buy
+28,466
New +$1.63M 0.7% 47

Other funds holding HALO

Horizon Investment Services's HALO Position: Q1 2026 in Review

Horizon Investment Services increased its Halozyme (HALO) stake by 0.59% in Q1 2026, buying an estimated $12.7K and bringing the position to 30,892 shares worth $2M. The position accounts for 0.69% of the portfolio, ranked #46.

Horizon Investment Services first reported a position in HALO in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.22M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Horizon Investment Services held 30,892 shares of Halozyme worth $2M as of Q1 2026.
  • Horizon Investment Services bought 180 Halozyme shares in Q1 2026, an estimated $12.7K.
  • Halozyme made up 0.69% of Horizon Investment Services's portfolio in Q1 2026, its #46 holding.
  • Horizon Investment Services first reported a position in Halozyme in Q3 2024 and has held it in 7 quarters since.
  • Horizon Investment Services's Halozyme position peaked at $2.22M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Horizon Investment Services's 13F filing for Q1 2026, filed 15 May 2026.